コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 still recommend fluoroquinolones for enteric fever.
2 gents of dengue fever and dengue hemorrhagic fever.
3 ible for dengue fever and dengue hemorrhagic fever.
4 esented faster clearance of parasitaemia and fever.
5 virus (SHFV) causes lethal viral hemorrhagic fever.
6 ct against S. sonnei shigellosis and typhoid fever.
7 available to effectively treat severe Lassa fever.
8 s, enveloped viruses that cause haemorrhagic fever.
9 of epidemic levels of Rocky Mountain spotted fever.
10 ally available vaccine against African swine fever.
11 s and to know which pathogens actually cause fever.
12 of ultrasound as a screening tool in dengue fever.
13 ulosis to 8043 (95% CI 7621-8464) for yellow fever.
14 ed that ZIKV infection most resembles dengue fever.
15 its 100th birthday for the treatment of hay fever.
16 responsible for severe cases of hemorrhagic fever.
17 against viremia and telemetrically monitored fever.
18 sitive and 95 cases were negative for dengue fever.
19 of non-structural protein 1 (NS1) of dengue fever.
20 childhood and cause diarrhea, vomiting, and fever.
21 ring investigations on the ecology of yellow fever.
22 cluster of human cases of severe hemorrhagic fever.
23 cause epidemics of highly fatal hemorrhagic fever.
24 in an animal model many symptoms of typhoid fever.
25 lacement for the ELISA for viral hemorrhagic fevers.
26 ents who received gemcitabine and docetaxel, fever (18 [12%] and 19 [15%]), and neutropenia (22 [14%]
27 syndromes (CAPS) and familial Mediterranean fever, 2 archetypical monogenic autoinflammatory syndrom
28 les (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less likely to have wheeze (30% v
34 an association of the prenatal occurrence of fever, a common manifestation of infection, with ASD ris
36 oxiella burnetii is the causative agent of Q fever, a zoonotic disease that threatens both human and
37 atible with trichinellosis, characterized by fever, abdominal pain, and diarrhea, along with eosinoph
38 rickettsia, the etiological agent of spotted fever, able to activate dendritic and macrophage cells.
39 a proportion of KD patients have persistent fever after IVIG treatment and are defined as IVIG resis
40 ined the causal effect of BMI on asthma, hay fever, allergic sensitization, serum total immunoglobuli
41 ality depending on the country - namely 'hay fever', 'allergy' and 'pollen' - showing cultural differ
44 examined the causal effect of smoking on hay fever and asthma by using the smoking-associated single
46 ed study suggested that prenatal exposure to fever and common infections does not affect the child's
49 valuable technique in diagnosis of chronic Q fever and during follow-up, often leading to a change in
52 nfectious diseases such as dengue and yellow fever and emerging diseases such as Zika and chikungunya
54 ytopenia (four [25%]), anaemia (four [25%]), fever and infection (four [25%]), and hypoxia (four [25%
60 nsistently positively associated with recent fever and malaria but not with other recent illnesses.
62 rage in children younger than 5 years with a fever and P falciparum infection increased across sub-Sa
64 sistent symptoms for more than 10 days, high fever and purulent nasal discharge or facial pain lastin
65 y used cross-sectional data on treatment for fever and RDT status for children younger than 5 years c
67 nitial manifestation with progression to hay fever and then asthma, there is yet no definitive proof
68 SAgs are known virulence factors in scarlet fever and toxic shock syndrome, mechanisms by how SAgs c
76 ve agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome and is endemic to tropi
78 ed with concomitant diagnoses of asthma, hay fever, and food allergy and increased disease severity.
79 Early IgE sensitization onset, parental hay fever, and higher exposure to mites were associated with
81 lanine aminotransferase (ALT) elevation with fevers, and grade 3 pulmonary infection with grade 3 mac
86 10 postimmunization.IMPORTANCE African swine fever (ASF) is endemic in Africa, parts of the Trans Cau
90 DMH-lesioned rats also could not develop fever autonomically: they did not increase thermogenesis
91 les from participants >/=2 years of age with fever (axillary temperature of >/=37.5 degrees C) or wit
94 tinel sites with previous reports of typhoid fever: Burkina Faso (two sites), Ethiopia, Ghana, Guinea
95 riodicity in population incidence of scarlet fever but of consistently lower magnitude than the curre
96 virus infection typically causes mild dengue fever, but, in severe cases, life-threatening dengue hem
97 tcome was clearance of asexual parasites and fever by day 7, and absence of recrudescent infection by
106 ragmatic guideline (presence of haemoptysis, fever, chronic cough, weight loss, night sweats, and poo
109 s, and the threat of global spread of yellow fever, combined with the resurgence of dengue and chikun
110 myringotomy, measles, hepatitis A, rheumatic fever, common colds, rubella and chronic sinus infection
111 FUBC, antibiotic susceptibility, presence of fever, comorbidities (intravenous central lines, urinary
112 tion coverage for polio, measles, and yellow fever continued to decrease, whereas the trend in covera
115 he respiratory route and illness begins with fever, cough, coryza, and conjunctivitis followed by a c
116 alth Organization (WHO) 4-symptom screening (fever, cough, night sweats, and weight loss), a rapid te
120 irus (DENV) is the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndro
121 ight chain CDRs.IMPORTANCE A chimeric yellow fever-dengue live-attenuated tetravalent vaccine is now
122 nofi Pasteur has developed a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccin
123 he gold-standard immunoassay for hemorrhagic fever detection has been the enzyme-linked immunosorbent
124 with dengue experience mild disease, dengue fever (DF), while few develop the life-threatening disea
129 e ultrasound findings cannot rule out dengue fever due to the low sensitivity of this examination.
130 ancy, maternal conditions including anaemia, fever during labour, and hypertension accounted for most
131 fevers in Africa, Crimean-Congo haemorrhagic fever, Ebola virus disease, Lassa fever, and Marburg vir
133 the risk of allergies/atopies including hay fever, eczema, food allergy, positive skin prick testing
134 vels and a strong propensity for asthma; hay fever; eczema; and impaired lung function, also in child
135 f clinical and epidemiological features of Q fever endocarditis collected through passive surveillanc
139 mentous RNA virus causing severe hemorrhagic fever, enters cells by macropinocytosis and membrane fus
141 ased markedly with exposure to three or more fever episodes after 12 weeks' gestation (aOR, 3.12; 1.2
142 Coxiella burnetii, the causative agent of Q fever, establishes a unique lysosome-derived intracellul
149 admitted to the hospital on the third day of fever from November 2013 through August 2015 were includ
151 e, grade 4 hypotension with grade 3 rash and fevers, grade 4 aspartate aminotransferase (AST) or alan
152 symptomatic (>/=2 signs/symptoms, including fever >/=37.8 degrees C, headache, myalgia, cough, sore
157 ses, such as cholera, meningitis, and yellow fever, have become common over the past decade, hamperin
159 K hospital with acute respiratory illness or fever higher than 37.5 degrees C (</=7 days duration), o
166 hogenic virus that causes severe hemorrhagic fever in humans and is responsible for epidemics through
169 e also found loss of circadian resistance to fever in Lhx1 but not Vip mice, which was partially reca
170 ncreased ASD risk, adjusting for presence of fever in other trimesters and confounders (adjusted odds
171 relative proportion of children with enteric fever in the age groups <5 years, 5-9 years, and 10-14 y
172 e of >/=37.5 degrees C) or with a history of fever in the preceding 48 h were tested with UMT and mic
173 ndemic potential for four viral haemorrhagic fevers in Africa, Crimean-Congo haemorrhagic fever, Ebol
175 inical failure criteria at follow-up visits: fever; increase in erythema (>25%), swelling, or tendern
177 nificant disabilities, related to an acute Q fever infection, without other somatic or psychiatric co
181 nical evaluation.IMPORTANCE EBOV hemorrhagic fever is one of the most lethal viral infections and lac
183 yaro virus (MAYV), causative agent of Mayaro Fever, is an arbovirus transmitted by Haemagogus mosquit
184 including polio, measles and rubella, yellow fever, Japanese encephalitis, rotavirus, and invasive ba
186 autoinflammation and vasculopathy (recurrent fevers, livedo reticularis, polyarteritis nodosa, lacuna
187 -4 cytokine release syndrome, with prolonged fever (median, 6.5 d), hyperferritinemia (median peak fe
188 disease caused by mutations of Mediterranean fever (MEFV) encoding pyrin and characterized by inflamm
191 ne may be an interkingdom cue for the yellow fever mosquito, Aedes aegypti, seeking blood-meals as we
193 omen to report anorexia, asthenia, diarrhea, fever, myalgias/arthralgias, nausea, or vomiting (P < .0
194 porting both wheeze and doctor-diagnosed hay fever (n = 1,310, 6%) and non-allergic wheeze as reporti
195 13%), nonspecific signs and symptoms, e.g., fever (n = 281; 13%), and gastrointestinal or genitourin
196 ergic wheeze as reporting wheeze but not hay fever (n = 3,939, 18%); men without wheeze were the refe
197 individuals can also experience hemorrhagic fever, neurological disorders, liver failure, and blindn
201 e children according to prenatal exposure to fever (odds ratio (OR) = 1.01, 95% confidence interval (
206 t failure and renal failure, with absence of fever or hypotension, and in inpatient-presenting sepsis
207 aken from adult and paediatric patients with fever or suspicion of sepsis admitted to Queen Elizabeth
208 smokers showed a slightly lower risk of hay fever (OR = 0.958, 95% CI: 0.920, 0.998; P = 0.041), a l
209 [1.22-3.16], history of atopic disease (hay fever: OR: 5.50 [3.42-9.00] and atopic dermatitis: OR 3.
210 factors to the ongoing spread of the yellow fever outbreak and provide estimates of the areas that c
211 Ebola virus causes devastating hemorrhagic fever outbreaks for which no approved therapeutic exists
215 rculosis test results, strep throat, scarlet fever, pneumonia, bacterial meningitis, yeast infections
217 ividual data from 2092 patients with enteric fever randomized into 4 trials in Kathmandu, Nepal, were
218 her risk of the well-known adverse events of fever, rash, and convulsions within the first 14 days.
220 or of Salmonella Typhi (the cause of typhoid fever), recapitulates in an animal model many symptoms o
221 investigated 7563 children with </=3 days of fever recruited in the outpatient departments of 6 hospi
224 es, the underlying cause of the individual's fever remains unknown due to potential coinfection with
226 43% and 52% of the population within yellow fever risk zones, compared with between 66% and 76% of t
227 terature on the use of ultrasound for dengue fever screening; hence, the primary objective of the stu
228 , with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative
233 inflammatory diseases, ranging from periodic fever syndromes caused by dysregulated inflammasome-medi
234 rtly thereafter, the infected rats exhibited fever, tachypnea, and hypertension that persisted for 24
238 linical outcomes, ranging from mild rash and fever to severe neurological complications and congenita
240 oproxil fumarate for 8 months presented with fever, urinary tract infection caused by Escherichia col
241 ce-provider registeries) reporting on yellow fever vaccination activities between May 1, 1939, and Oc
242 r results highlight important gaps in yellow fever vaccination coverage, can contribute to improved q
243 he population who had ever received a yellow fever vaccine for each second level administrative divis
244 d datasets describing the epidemic of yellow fever, vector suitability, human demography, and mobilit
245 ce resulted in increased morbidity-including fever, viremia, and viral loads in spinal cord and teste
253 domains of two pestiviruses, classical swine fever virus (CSFV) and border disease virus (BDV), are r
254 Treatment of blood samples from hemorrhagic fever virus (HFV)-infected patients with 0.1% detergents
255 ncluding the Old World (OW) arenavirus Lassa fever virus (LASV) and the New World (NW) Junin virus (J
257 cluding Zaire ebolavirus (EBOV), Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus
258 t to combat infections caused by Rift Valley fever virus (RVFV), which causes devastating disease in
259 ab-eating macaques, while simian hemorrhagic fever virus (SHFV) causes lethal viral hemorrhagic fever
260 ting macaques with either simian hemorrhagic fever virus (SHFV) or Kibale red colobus virus 1 (KRCV-1
262 we address this issue using the live yellow fever virus (YFV) vaccine, which induces long-term immun
263 y important human pathogens including yellow fever virus (YFV), dengue virus (DENV), and Zika virus (
264 ls specific for a single epitope from Yellow Fever Virus (YFV), we show that the recently described '
265 hts into how a prototypic flavivirus, yellow fever virus (YFV-17D), differentially interacts with mur
266 e the 2 flaviviruses dengue virus and yellow fever virus and the alphavirus chikungunya virus, which
267 model to infer the district-specific yellow fever virus infection risk during the course of the epid
268 sed the benefits of adding the African swine fever virus NP868R capping enzyme during reovirus rescue
270 quire vaccination in areas at risk of yellow fever virus transmission to achieve the 80% population c
272 of the nucleocapsid (N) mRNA of Rift Valley fever virus, a phlebovirus of the Bunyaviridae family, a
273 luster of viruses encompassing African swine fever virus, faustovirus, pacmanvirus, and kaumoebavirus
274 31 genes are conserved between African swine fever virus, pacmanvirus, faustovirus, and kaumoebavirus
279 e evaluation of vaccines against paratyphoid fever, we aimed to develop the first human challenge mod
280 es at triage and during hospitalization were fever, weakness, anorexia, and diarrhea, although 21% of
281 vere form of leishmaniasis, characterized by fever, weight loss, hepatosplenomegaly, and lymphadenopa
284 We estimate that 35.7% of all self-reported fevers were accompanied by a malaria infection in 2014,
286 ral viruses that can cause viral hemorrhagic fever, which is characterized by uncontrolled immune act
287 There are no approved treatments for Lassa fever, which is endemic to the same regions of West Afri
288 adult Dutch patients suspected of chronic Q fever who were diagnosed since 2007 were retrospectively
289 pathogen responsible for dengue hemorrhagic fever, whose global incidence has increased dramatically
290 Approximately 20% of patients with acute Q fever will develop chronic fatigue, referred to as Q fev
297 tion of children younger than 5 years with a fever within the previous 14 days and P falciparum infec
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。